IFI27 and systemic lupus erythematosus: The literature harbors many inflammatory/immunological conditions including inflammatory bowel diseases, psoriasis, systemic lupus erythematosus, Sjögren's syndrome, antiphospholipid syndrome, acute graft‐versus‐host disease, immune thrombocytopenic purpura, Aicardi−Goutieres syndrome, Kikuchi−Fujimoto, and hand, foot, and mouth diseases, in which significant increases in IFI27 expression have been reported.39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50